Keyword Analysis & Research: Press Releases
Keyword Research: People who searched Press Releases also searched
Search Results related to Press Releases on Search Engine
-
Newsroom | Johns Hopkins Medicine
https://www.hopkinsmedicine.org/news/newsroom/
webSign up to receive press releases and other breaking news from Johns Hopkins Medicine. Sign up for News. Follow the Johns Hopkins Medicine newsroom for the latest updates in medicine, scientific discovery, and next generation medical education, expert sources, and media contact information.
DA: 58 PA: 100 MOZ Rank: 34
-
JOHNS HOPKINS MEDICINE AND CAREFIRST REACH NEW …
https://www.hopkinsmedicine.org/news/newsroom/news-releases/2022/10/johns-hopkins-medicine-and-carefirst-reach-new-strategic-agreement
webOctober 26, 2022. Johns Hopkins Medicine and CareFirst BlueCross BlueShield (CareFirst) have agreed to a new multiyear contract to provide high-quality care options while building on a long-standing relationship and commitment to serving our shared communities.
DA: 77 PA: 9 MOZ Rank: 5
-
Johns Hopkins Medicine Joins Coalition of Health Systems, …
https://www.hopkinsmedicine.org/news/newsroom/news-releases/2024/02/johns-hopkins-medicine-joins-coalition-of-health-systems-hospitals-and-the-ad-council-in-tackling-an-urgent-public-health-crisis-gun-violence
webFeb. 27, 2024 – Johns Hopkins Medicine is among a group of health systems and hospitals backing a gun violence prevention initiative announced today to address this urgent public health crisis and its impact on youth.
DA: 51 PA: 26 MOZ Rank: 2
-
Psilocybin Treatment for Major Depression Effective for Up to a …
https://www.hopkinsmedicine.org/news/newsroom/news-releases/2022/02/psilocybin-treatment-for-major-depression-effective-for-up-to-a-year-for-most-patients-study-shows
webFeb 15, 2022 · The researchers emphasize that further research is needed to explore the possibility that the efficacy of psilocybin treatment may be substantially longer than 12 months. Johns Hopkins is one of the sites of a national multisite randomized, placebo-controlled trial of psilocybin for major depressive disorder.
DA: 93 PA: 30 MOZ Rank: 20
-
News Releases | Johns Hopkins Medicine
https://www.hopkinsmedicine.org/news/newsroom/news-releases/
web03/19/2024. Study Suggests An ‘Odor Sensor’ May Explain Male and Female Differences in Blood Pressure. 03/18/2024. Johns Hopkins Medicine-Led Team Develops Fluid Biomarker for Early Detection of Degenerative Diseases ALS And FTD. 03/13/2024. RNA-Based Therapy Shows Promise Against Aggressive Childhood Brain Tumors in Mice. 03/13/2024.
DA: 35 PA: 71 MOZ Rank: 42
-
Get the Latest News from Johns Hopkins Medicine
https://www.hopkinsmedicine.org/news/
webSee recent press releases, search for contacts by beat and more. Podcasts. Browse our podcast categories or listen to all medical related podcasts available from Johns Hopkins experts. Publications. Choose from over 30 publications and find the latest in patient care, surgery, biomedical research and alumni news. Social Media.
DA: 42 PA: 93 MOZ Rank: 7
-
Johns Hopkins Medicine Receives First Federal Grant for …
https://www.hopkinsmedicine.org/news/newsroom/news-releases/2021/10/johns-hopkins-medicine-receives-first-federal-grant-for-psychedelic-treatment-research-in-50-years
webOct 18, 2021 · Home News and Publications Newsroom All News Releases. Johns Hopkins Medicine Receives First Federal Grant for Psychedelic Treatment Research in 50 years. 10/18/2021. A cluster of Cubensis (magic mushrooms). Credit: Paul Stamets. Fast Facts. Click to Tweet. Can #psilocybin help smokers quit?
DA: 36 PA: 30 MOZ Rank: 97
-
New Research Sheds Light on Cause of Type 2 Diabetes
https://www.hopkinsmedicine.org/news/newsroom/news-releases/2023/09/new-research-sheds-light-on-cause-of-type-2-diabetes
web09/13/2023. Matthew N. Poy, Ph.D., Johns Hopkins All Children's Hospital. St. Petersburg, Fla. – September 12, 2023 – Scientists at Johns Hopkins All Children’s Hospital, along with an international team of researchers, are shedding new light on the causes of Type 2 diabetes.
DA: 77 PA: 80 MOZ Rank: 53
-
Study Shows Paxlovid Can Safely Be Used to Reduce Risk of …
https://www.hopkinsmedicine.org/news/newsroom/news-releases/2022/11/study-shows-paxlovid-can-safely-be-used-to-reduce-risk-of-severe-covid-in-people-who-are-pregnant
web11/29/2022. According to a new study by Johns Hopkins Medicine researchers, Paxlovid — a combination of two drugs — can safely be used to reduce the risk of severe COVID-19 from SARS-CoV-2 infection in a person who is pregnant.
DA: 70 PA: 52 MOZ Rank: 52
-
News Release Archive - Johns Hopkins Medicine
https://www.hopkinsmedicine.org/news/media/releases/
webDec 20, 2017 · Current News Releases. 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 Released: December 28, 2017 Study Shows Increased Risk of Uterine Fibroids in African-American Women With a Common Form of Hair Loss. In a study of medical records gathered on hundreds of thousands of African-American women, Johns Hopkins …
DA: 41 PA: 17 MOZ Rank: 43